Buying from the EU? See PT-141 for European research buyers.

PT-141 (bremelanotide) is a synthetic melanocortin-receptor agonist and active metabolite of Melanotan 2, studied for centrally-mediated sexual-response pathways. Supplied lyophilised for laboratory research use only.
PT-141 (bremelanotide) is a synthetic melanocortin-receptor agonist and an active metabolite of Melanotan 2. Unlike vascular-acting compounds, it is studied for centrally-mediated effects on sexual-response pathways via the MC4 receptor in the central nervous system.
Its mechanism is of research interest precisely because it acts on neural signalling rather than peripheral blood flow, and it has been evaluated in controlled clinical trials for hypoactive sexual desire.
| Area | Reported research focus |
|---|---|
| Sexual-response pathways | Centrally-mediated MC4R signalling in clinical cohorts. |
| Melanocortin system | Receptor-subtype pharmacology. |
| Specification | Detail |
|---|---|
| Product | PT-141 |
| Format | Lyophilised vial |
| Fill | 10 mg per vial |
| Molecular formula | C50H68N14O10 |
| Purity | Specified to a 99%+ purity target — per-batch documentation will be published once independent lab testing completes |
| Price | €40.00 |
| Availability | In stock — dispatched from Ireland within 1–2 working days, tracked |
| Supplied for | Laboratory research use only — not for human consumption, diagnostic or therapeutic use |
Every production batch is sent for independent, third-party analysis at Janoshik Analytical. When results return, the full Certificate of Analysis for the exact batch you receive is published here and in our COA library, carrying its SHA-256 checksum and the lot number printed on your vial, so you can confirm the document is genuine and untampered. We publish every certificate, including any that fail.